Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
Nature Medicine2003Vol. 9(6), pp. 729–735
Citations Over TimeTop 1% of 2003 papers
Samuel McConkey, William H. H. Reece, Vasee Moorthy, Daniel Webster, Susanna Dunachie, Geoff Butcher, Jenni M. Vuola, Tom Blanchard, Philip Gothard, Kate E. Watkins, Carolyn M. Hannan, S. Everaere, Karen Brown, Kent E. Kester, James F. Cummings, Jackie Williams, D. Gray Heppner, Ansar A. Pathan, Katie L. Flanagan, Nirmalan Arulanantham, Mark Roberts, Michael J. Roy, Geoffrey L. Smith, J Schneider, Tim Peto, Robert E. Sinden, Sarah C. Gilbert, Adrian V. S. Hill
Related Papers
- → IMVAMUNE®: modified vaccinia Ankara strain as an attenuated smallpox vaccine(2008)125 cited
- → Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naïve and vaccinia-immune individuals(2006)95 cited
- → Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse(2001)74 cited
- → Chicken IL-7 as a potent adjuvant enhances IBDV VP2 DNA vaccine immunogenicity and protective efficacy(2016)22 cited
- Evaluation of Immunogenicity of Pasterurella haemolytica Serotypes in Experimental Models(2000)